Latest Connective tissue diseases Stories
Tokyo, Sept 11, 2012 - (JCN Newswire) - Eisai Co., Ltd. announced today that it will launch the anti-rheumatic agent Careram(R) (iguratimod) in Japan on September 12 for the treatment of rheumatoid arthritis. Careram, jointly developed in Japan by Eisai and Toyama Chemical Co., Ltd. from the Phase III clinical development stage, was approved by Japan's Ministry of Health, Labour and Welfare (MHLW) in June of this year and was subsequently listed on the National...
redOrbit Staff & Wire Reports – Your Universe Online A Massachusetts-based bio-pharmaceutical company is developing a new treatment for autoimmune diseases from a parasite found in pig feces, Reuters writer Toni Clarke reported on Friday. Coronado Biosciences, based in the town of Burlington, is currently working on a new drug consisting of thousands of microscopic parasite eggs removed from the droppings of the large-snouted, hoofed mammals, Clarke said. The eggs are suspended...
The research relates to a family of molecules firstly discovered in Melbourne that applied to blood cell development. One of these, granulocyte macrophage colony-stimulating factor or GM-CSF, acts as a messenger between cells acting at a site of inflammation. Professor John Hamilton has posed the question: could blocking GM-CSF action lead to a new treatment for inflammatory diseases? In experimental models of rheumatoid arthritis, Professor Hamilton and Dr Andrew Cook had previously shown...
Might be potential trigger and/or help sustain inflammation suggest researchers Gum disease is not only four times as common among patients with the autoimmune disease rheumatoid arthritis as it is among their healthy peers, but it also tends to be more severe, indicates a small study published online in the Annals of the Rheumatic Diseases. The researchers base their findings on 91 adults with confirmed rheumatoid arthritis (RA) and a comparison group of 93 healthy people, matched for...
HAYWARD, Calif., Aug. 7, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended June 30, 2012. Financial Results: Total operating expenses for the second quarter ended June 30, 2012 were $16.7 million, as compared to $20.1 million for the first quarter ended March 31, 2012. The decrease in operating expenses for the period is related to the reduced clinical activity following the completion...
NEW YORK, Aug. 7, 2012 /PRNewswire/ -- Sjogren's Syndrome is a chronic autoimmune disease in which a person's white blood cells attack their moisture-producing glands. It is estimated that this disease affects as many as 4 million Americans, most of which are women. Those living with the disease are afflicted with dryness in various parts of their body and typically are also pained by other autoimmune disorders, such as rheumatoid arthritis or systemic lupus erythematosus....
The Lupus Foundation of America's Summer Issue of Lupus Now(®) Magazine highlights athlete's journey as a professional soccer player living with lupus WASHINGTON, July 25, 2012 /PRNewswire-USNewswire/ -- Shannon Boxx, a 34-year-old professional soccer player from California, has dedicated her life to scoring goals -- both on and off the field. Boxx is a two-time Olympic gold medalist, a three-time member of the U.S. Women's World Cup team, and has played for the past three years...
NEW YORK, July 25, 2012 /PRNewswire/ -- Pharmspective, LLC, the specialty therapeutics market research firm, announced today the release of its two newest syndicated market research reports, Rheumatoid Arthritis Pipeline Perspectives - http://bit.ly/MjeXFo and Psoriasis Pipeline Perspectives - http://bit.ly/PKpqK0 These new Pharmspective reports coincide with a number of key milestones in Rheumatoid Arthritis (RA) & Psoriasis product development: Tofacitinib 2nd line...
RA patients emphasize pain, physicians stress swollen joints to explain change in disease Researchers from Austria have determined that patients with rheumatoid arthritis (RA) and their doctors differ on perception of RA disease activity. The study now available in Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR) and published by Wiley, reports that RA patients cite joint pain as the reason for their perception of a change in their disease activity....
NEW YORK, July 17, 2012 /PRNewswire/ -- Hollow, sunken eyes plagued with dark circles give us an instant tired, old and unwell look. While many turn to cosmetic surgery and laser technology to treat the eye area, Dr. Bruce Katz, director of the JUVA Skin & Laser Center in New York, is pioneering a new, safe technique that dramatically reduces dark circles and hollows making eyes look brighter and rejuvenated. By utilizing a natural filler called Selphyl® in the tear troughs...
